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ABSTRACT
Objective: Nanoparticle-based drug delivery is the currently focused area in case of various therapeutic and diagnostic techniques. Iron oxide 
nanoparticles are used as carriers in drug delivery due to their unique properties and negligible side effects.
Methods: We analyze the potential therapeutic properties of methanolic extracts of Centella asiatica loaded with polyvinylpyrrolidone (PVP) iron 
oxide nanoparticles against human breast cancer cell lines michigan cancer foundation - 7 type (MCF-7), and the results were compared with normal 
cell lines. Characterization of coated nanoparticles was done by ultraviolet - visible (UV-VIS) spectroscopy, Fourier transform infra-red spectroscopy 
(FTIR) and particle size analyzer. Loading of herbal drug extract to nanoparticles was confirmed using TEM, particle size analyzer, FTIR, and 
biochemical assays. Initially, dose-depended hydrogen peroxide free radical scavenging activity was recorded.
Results: Methanolic extracts of C. asiatica showed 55, 59, 71, and 80% inhibition, respectively. MTT assay (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium) was performed to estimate the drug loading efficiency for PVP-coated iron oxide nanoparticle at 1 hr and 24 hrs. At 10 µl 
concentration, methanolic extracts of C. asiatica loaded PVP-coated iron oxide nanoparticles exhibited significant cell necrosis in breast cancer cell 
line MCF-7 as 60%. In the case of normal cell lines - fibroblast cell lines (L929), the cytotoxicity was reduced to 10.42, respectively.
Conclusion: This work was aimed to increase the efficiency, reduce side effects of chemotherapeutic drugs, and provide conveniences for the future 
therapeutics by coupling herbal drug with polymer-coated nanoparticles.
Keywords: Iron oxide nanoparticles, Chemotherapy, Herbal drug, Anticancer activity.
INTRODUCTION
Breast cancer is a major public health problem in developed countries 
like the United States and rising issue in India [1,2]. It is the most 
common cancer in women and the leading cause of cancer death 
among women 25-60 years of age [3]. The international agency for 
research on cancer estimates 411,000 deaths occur among 1.15 million 
diagnosed cases [4]. The rising incidence and poor prognosis of breast 
cancer cases have prompted a search for additional preventive and the 
therapeutic modalities [5].
Nano-biotechnology is the most advancing field of nanoscience 
which involves nanoparticles for various biomedical applications 
and therapeutic treatment for cancers [6]. Due to unique biological 
effects nanoparticles show different molecular approach from 
traditional small molecules to complicated drugs [7]. European Science 
Foundation points out the need for larger investments in developing 
nanotechnological tools in diagnostics and therapeutics for various 
diseases [8]. The modern treatment for cancers shows several side 
effects and produce toxicity to both cancer and normal cells. Even 
chemotherapy is often limited by important side effects and is non-
specific to cancer or tumor cells, leading to serious damage to healthy 
cells [9]. Nanoparticles coated with natural drugs are implemented as 
drug delivery for cancer treatment because of their intrinsic physical 
properties and their ability to target specific cancer tissues and prevent 
toxicity to healthy tissues [10,11].
Iron oxide nanoparticles are widely used drug delivery agents in 
cancer diagnosis [12]. Iron oxide nanoparticles have been applied 
as magnetic contrast agents for over 45 years. Now, it is successfully 
employed in the biomedical applications for blood pooling, tissue and 
as target cell specific agents for magnetic resonance imaging in cancer 
diagnostics [13]. Apart from several clinical applications of Iron oxide 
nanoparticles, there are many reports about the toxicity produced 
by these nanoparticles when it interacts with biological systems. 
Iron oxide nanoparticles induced reactive oxygen species creating 
an oxidative stress on the cell which results in cytotoxicity. Oxidative 
stress caused by iron oxide nanoparticles will damage DNA and this 
damage to genetic content will lead to apoptosis. Nanoparticles coated 
with the polymer membrane show promising decrease or reduction 
in the toxicity and this method is widely followed in the field of drug 
delivery [14].
The scientific community is attracted toward medicinal plants as a 
source of drugs for various diseases and approximately 64% of the 
global population uses traditional medicine due to less cost and lower 
side effects compared to modern drugs [15]. Centella asiatica is widely 
used medicinal plants to treat various diseases [16]. C. asiatica, a plant 
of the family Umbelliferae, is commonly known as gotakola. It commonly 
grows in damp areas in tropical countries and is used traditionally 
as a multipurpose medicinal plant in the treatment of cancer, neuron 
diseases, wound healing, tuberculosis, lumps, etc [13]. The plant is 
widely used as a tonic in skin diseases and leprosy. In addition, the 
flavonoids of this plant have antiulcer, antitumor, and wound healing 
activity [17]. The present study aims to examine the potentials of 
Rauwolfia serpentina and C. asiatica as anticancer drugs loaded onto 
polymer-coated nanoparticles against human breast cancer cell lines 
michigan cancer foundation-7 (MCF-7).
Among the many polymers used as protective coating for drug delivery, 
PVP is most common due to its varied biological applications. PVP was 
reported as an effective plasma substitute due to its hydrophilic nature 
and non-toxicity. PVP-coated silver nanoparticles are already used in 
complicated cases of serious burns and purulent wounds due to its 
antiseptic properties [18]. Another report suggests that PVP-based 
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drug delivery enhanced gene expression in muscle tissue and also 
protect plasmid DNA from nuclease degradation [19]. PVP is known 
as a biologically friendly polymer. They are currently used in various 
biomedical applications such as the artificial pancreas, synthetic 
vitreous body, wound dressing, artificial skin, cardiovascular devices, 
and other biomedical applications [20]. Combining such properties 
of these polymer-coated nanoparticles along with the natural drug 
may lead to possible preparations of new effective drugs for cancer 
diagnostics. Nanoformulation of herbal extracts from C. asiatica is 




The plant material C. asiatica were collected from the nearby Veli Hills 
and were identified and confirmed by Botanical experts. The fresh 
leaves were cleaned, shade dried, and reduced into a coarse powder 
in a Wiring blender. The plants powdered were subjected to soxhlet 
extraction (70±10°C temp.) with methanol as a solvent in 1: 4 (w/v) 
ratios for 18 hrs. The extracts were concentrated using a rotary vacuum 
evaporator (40°C; pressure 70±5 psi); thick, brown mass obtained was 
kept in vacuum desiccators for complete drying. The dried extracts were 
stored in an airtight container and kept in the refrigerator (8±2°C), and 
the same was used for in vivo and in vitro studies.
Phytochemical screening
The preliminary phytochemical screening was carried out according 
to the procedure given by Harborne [21], which revealed the presence 
of lipids, carbohydrates, flavonoids, and alkaloids in both the plant 
extracts.
In vitro antioxidant activity
The plant extracts were dissolved in 3, 4 ml of 0.1 mol phosphate buffer 
(pH-7.4) and mixed with 600 ml of 43 mmol solution of hydrogen 
peroxide. The absorbance value (at 230 nm) of the reaction mixture 
was recorded from 0 to 40 minutes and then at every 10 minutes. For 
each concentration, a separate blank sample was used for background 
subtraction. The percentage H2O2 scavenging activity of the synthesized 
compounds and standard compound was calculated as:
H2O2 scavenging effect (%) = ([V0-V1]/V0) × 100
Where,
V0 = Absorbance of control
V1 = Absorbance of the sample.
Synthesis of iron oxide nanoparticles
The stock solution preparation includes: 3.85 g of ferric chloride was 
added to 50 ml of double distilled water to make a solution of 1 mol. 
6 g of ferrous chloride was added to 50 ml of distilled water to make 
a solution of 2 mol. 2 g of NaOH was added to 50 ml of distilled water 
to make a solution. For preparing the iron oxide nanoparticles 8 ml of 
1 mol ferric chloride and 2 ml of 2 mol ferrous chloride was mixed and 
stirred. While stirring NaOH solution was added drop by drop until the 
solution turned brown. After preparing iron oxide nanoparticles, 5 g of 
PVP was added and sonicated for 30 minutes. Then, the mixture was 
heated for 30 minutes at 600°C.
Drug loading into PVP-coated and uncoated iron oxide 
nanoparticles
Drug loading can be done by two methods, i.e., incorporation and 
incubation. In these systems, the drug is embedded into the matrix or 
adsorbed onto the surface. The efficiency of loading is largely dependent 
on the method of preparation and physicochemical properties of the 
drug. The anticancer herbal drugs from C. asiatica were chosen as drugs. 
The drug loading was carried out by dispersing 5 mg of PVP-coated iron 
oxide nanoparticles in 5 ml aqueous plant extract solutions and 5 mg 
uncoated iron oxide 5 ml aqueous plant extract solutions consecutively. 
The mixture of PVP-coated iron oxide nanoparticles in herbal drug 
(test solution) and PVP-uncoated iron oxide nanoparticles in herbal 
drug (control solution) can be shaken in a rotary shaker (200 rpm) at 
37°C for 26 hrs. The drug loading can be determined as the difference 
between the initial drug concentration and the drug concentration in 
the supernatant. The drug loaded magnetic nanoparticles was then 
magnetically separated and dried.
Loading Efficiency(%)=
UV absorbance of drug
UV absorbance 
−
of drug in supernatant
UV absorbance of drug
CHARACTERIZATION OF SYNTHESIZED, POLYMER COATED, AND 
UNCOATED NANOPARTICLES
Fourier transform infra-red spectroscopy (FTIR) spectroscopy
The ATR-FTIR measurements were performed on a Bruker Eco Alpha-T 
FTIR spectrometer (Bruker, Karlsruhe, Germany) equipped with a 
mid-infrared source (SiC) and a thermal detector, such as deuterated, 
L-alanine doped triglycine sulfate premium performance pyroelectric 
detector. Spectra were collected at room temperature under atmospheric 
pressure, at an average of 64 scans with a resolution of 4/cm resolution 
in ATR mode from 400 to 5000/cm. In all experiments, background 
spectra were measured. FTIR spectroscopy measurements were 
carried out to recognize the chemical functional group in the sample. 
FTIR samples were prepared by drying sample with nanoparticles at 
60°C. The dried samples were subjected to FTIR measurement.
UV-visible spectroscopy
The UV/Vis spectra of surface plasmon resonances of iron oxide 
nanoparticles were analyzed using Systronics (India) double beam 
spectrophotometer (Model no. M2202). The range of measurement 
is taken from 200 to 1100 nm. Blanks were prepared with distilled 
and deionized (DI) water using a Milli-Q water purification system 
(Millipore Corp.).
Particle size analyzer
The mean particle size of PVP-coated, uncoated iron, and drug-loaded 
nanoparticles was estimated using a particle size analyzer, DC 12000, 
CPS Instruments USA. Particle Analyzer is used to characterize the size 
distribution of particles in a given sample. Particle size analysis can be 
applied to solid materials, suspensions, emulsions, and even aerosols. 
There are many different methods employed to measure particle size.
Transmission electron microscopy (TEM)
The size of PVP-coated, uncoated nanoparticles, and drug-loaded iron 
nanoparticles were visualized by TEM (Hitachi H-7650 Tokyo, Japan) 
operating at 80 kV. TEM is a microscopy technique whereby a beam of 
electrons is transmitted through an ultra-thin specimen, interacting 
with the specimen as it passes through. TEMs are capable of imaging 
at a significantly higher resolution than light microscopes, owing to the 
small de Broglie wavelength of electrons.
In vitro cytotoxicity study
L929 Fibroblast cells and MCF-7 breast cancer cell lines were 
purchased from the National Centre for Cell Sciences (NCCS) Pune 
was maintained in Dulbecco’s modified eagles media (HIMEDIA) 
supplemented with 10% fetal bovine serum (Invitrogen) and grown 
to confluency at 37°C in 5% CO2 (NBS, EPPENDORF, GERMANY) in a 
humidified atmosphere in a CO2 incubator. The cells were trypsinized 
(500 µl of 0.025% trypsin in PBS/0.5 Mm EDTA solution (Himedia) for 
2 minutes and passaged to T-flasks in complete aseptic conditions. 1 µL, 
5 µL, and 10 µL of extracts were added to grown cells and incubated 
for 24 hrs. The % difference in viability was determined by standard 
MTT assay after 24 hrs of incubation. The cell culture suspension was 
washed with ×1 PBS and then added 30 µl of the MTT solution to the 
culture (MTT -5mg/ml dissolved in PBS). It was then incubated at 37°C 
for 3 hrs. MTT was removed by washing with ×1 PBS, and 200 µl of 
dimethyl sulfoxide (DMSO) was added to the culture. Incubation was 
done at room temperature for 30 minutes until the cell got lysed and 
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color was obtained. The solution was transferred to centrifuge tubes 
and centrifuged at top speed for 2 minutes to precipitate cell debris. OD 
was read at 540 nm using DMSO as blank.
% cell viability=(OD of test/OD of Control) 100×
RESULTS
Phytochemical screening
Terpenoids and indole alkaloid biochemical conformation tests 
were carried out with the extracts of C. asiatica. The presence of 
terpenoids was confirmed based on the reddish-brown coloration of 
the interface. Ehrlich test indicates the presence of indole alkaloids 
by the production of the red solution. The details of the study can be 
observed from Fig. 1.
Antioxidant assay
Hydrogen peroxide scavenging property of C. asiatica 0.5, 1, 1.5, 
and 2 ml, respectively, was compared to the blank solution having 
phosphate buffer with H2O2. The antioxidant properties exhibited by 
the methanolic extract are represented in Fig. 2. At 230 nm absorbance, 
80% hydrogen peroxide scavenging activity was absorbed for 2 ml 
concentration of C. asiatica.
UV-visible spectroscopy
Fig. 3a represents the absorption of Iron oxide nanoparticles dispersed 
in water at the wavelength of 286 nm. The UV-vis spectra of PVP revealed 
an absorption peak at the wavelength 464 nm. Fig. 3b UV-vis absorption 
of PVP-coated iron oxide nanoparticles shows a strong absorption at 
512 nm. The results correlated with previous observation. UV-vis 
spectra of the synthesized iron oxide nanoparticles were recorded. 
The absorption of iron oxide nanoparticles dispersed in water was at 
the wavelength of 286 nm. The spectrum obtained at nm represents 
the peak for PVP-coated Iron oxide nanoparticles. Fig. 3c denotes the 
UV-vis absorption of drug loaded PVP-coated iron nanoparticles shows 
a strong absorption at 572 nm.
FTIR spectroscopy
The IR spectroscopic analysis used to determine the chemical 
functional groups in the sample FTIR spectrum of PVP-coated iron 
oxide nanoparticle, C. asiatica plant extracts, and drug-loaded PVP-
coated iron nanoparticles. Fig. 4a represents the fingerprint of Fe3O4 
nanoparticles occurring mainly at 618/cm and the broad absorption 
3320/cm represent the stretch vibration of O-H bonds in hydroxyl 
groups which is absorbed by Fe3O4 nanoparticles. The small narrow 
peak at 2359/cm assigned to surface bulk O-H group in magnetite. 
PVP-coated iron oxide nanoparticle has a carbonyl group characteristic 
absorption at 1633/cm and 1657/cm. The samples with polymer 
coating red-shifted from 1660/cm and 1606/cm at a stretching 
mode, respectively (Fig. 4b). Fig. 4c represents the FTIR spectrum of 
C. asiatica with a strong peak at 1017/cm. OH bond indicates a broad 
peak at 3331/cm. Stretching frequency of alkyl group peak was shown 
at 1651/cm and 1450/cm. C-H bond indicates peak at 2929/cm and 
2836/cm. Drug loaded iron oxide nanoparticles showed a broad peak 
at 3313/cm. The strong peak at 1014 and 1646/cm indicated C-O bond. 
Polymer-coated iron oxide nanoparticles.
Particle size analysis
The particle size distribution of iron oxide nanoparticle, polymer-
coated iron oxide nanoparticle, and drug-loaded polymer-coated 
iron oxide nanoparticle were shown in Fig. 5a-c. The comparison of 
uncoated iron oxide nanoparticles with the polymer-coated iron oxide 
nanoparticles. Iron oxide nanoparticle shows the mean size of 198 nm 
while the polymer-coated iron oxide nanoparticle showed particle 
size as 202 nm. Drug loaded iron oxide nanoparticle shows size as 
275 nm.
Drug loading efficiency
In C. asiatica, the drug entrapment efficiency was calculated using 
UV-visible spectroscopy in 1 hr and 24 hrs. Drug loaded uncoated iron 
oxide nanoparticle have an efficiency of 75% at 24 hrs and drug loaded 
PVP-coated iron oxide nanoparticles with 78% at 24 hrs. The details 
can be observed from the Fig. 6a-d.
X-ray diffraction (XRD) studies
Fig. 7a and b show the XRD curves of Iron oxide nanoparticles both 
in polymer uncoated and coated forms, respectively. The main peak 
absorbed at 20=19 Å respectively. The XRD spectrum revealed a high 
degree of crystallinity of the iron oxide nanoparticle. The powder XRD 
was performed at room temperature with a Cu Kx radiation sources 
(=0.154056 nm). XRD pattern of Fe3O4 confirms the crystallinity of 
Fe3O4 nanoparticles. Using the Scherer’s equation, the crystalline grain 
diameter of the Fe3O4 particle was determined. The main peak of Fe3O4 
nanoparticle was observed at 20=30 Å, 35.5 Å, 43 Å, 53.5 Å, 57 Å, 62 Å 
correspond to 111, 311, 400, 511, and 440, respectively.
TEM
The TEM image of iron oxide nanoparticle, PVP-coated iron oxide 
nanoparticle, and drug loaded iron oxide nanoparticle are represented 
in Fig. 8a-c. 3-30 nm range of mean particle size obtained for iron oxide 
nanoparticle. The mean particle size obtained for PVP-coated iron 
oxide nanoparticles was in the range of 40-70 nm. Mean particle size 
obtained for the drug loaded iron oxide nanoparticles are in the range 
of 83-110 nm.
MTT assay for evaluation of apoptosis
The MTT assay was done against fibroblast cell lines (L929) and 
breast cancer cell lines (MCF-7). The MTT assay results revealed 
higher cell death in breast cancer cell lines (MCF-7) than fibroblast cell 
lines when the drug and the nanoparticles were supplied at different 
concentrations. The results of the cell distribution with confocal 
microscopy after treatment with the samples are represented in 
Fig. 9a-d. for the cell lines L929. The details of the cancer cell lines 
are represented in Fig. 10a-d. Table 1 represents the percentage of 
cell viability for the given cell lines for different concentrations of the 
sample. At the concentration of 10 µl, C. asiatica loaded iron oxide 
Fig. 1: Salkowski confirmation test for tri-terpenoids and indole 
alkaloids
Fig. 2: Antioxidant assay for the extract of Centella asiatica
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nanoparticle has high cell death as 60% in MCF-7 and 40% in the 
normal cell line (L929). 10µl of C. asiatica had shown a 49.8% in MCF-7 
and 29.6% in L929 cell lines. The obtained data are compared with the 
standard drug 5-fluorouracil.
Fig. 3: UV-visible spectroscopic studies of the samples. (a) UV-vis spectra of iron oxide nanoparticles (IONP), (b) UV-vis spectra of 
polyvinylpyrrolidone-coated IONP, (c) UV-vis spectra of drug loaded IONP
c
ba
Fig. 4: Fourier transform infra-red spectroscopy (FTIR) spectroscopy of the samples. (a) FTIR spectra of iron oxide nanoparticles, 
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Fig. 7: X-ray diffraction (XRD) analysis of the synthesized nanoparticles. (a) XRD spectra of Fe3O4, (b) XRD spectra of polyvinylpyrrolidone 
coated Fe3O4
Fig. 6: Analyzes of drug entrapment efficiencies of different samples at 1 hr and 24 hrs intervals. (a) Drug entrapment of iron 
nanoparticles at 1 hr, (b) Drug entrapment of polymer-coated iron nanoparticles at 1 hr, (c) Drug entrapment of iron nanoparticles at 
24 hrs, (d) Drug entrapment of polymer-coated iron nanoparticles at 24 hrs
dc
ba
Fig. 5: Determination of the particle size for the synthesized nanoparticles. (a) Particle size analysis of iron oxide nanoparticles (IONP), 
(b) Particle size analysis of polyvinylpyrrolidone (PVP)-coated IONP, (c) Particle size analysis of extracts of drug loaded PVP-coated IONP
ba
ba
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DISCUSSIONS
Nanoparticle-based cancer drug research pays attention to the 
scientific community because of their novel, intrinsic physical 
properties, and their abilities to target specific cells and mainly for 
minimizing severe side effects [22]. The most important thing is 
the functional, and structural properties of the nanosized particles 
are not seen in discrete molecules or in bulk materials. Several 
applications of nanoscale compounds were implemented in current 
clinical therapeutic such as biodegradable nanostructure for drug 
delivery, iron oxide nanocrystals for magnetic resonance imaging, 
quantum dots for multiplexed molecular diagnosis and in vivo 
imaging and nanoscale carriers for short interfering RNA (si-RNA) 
delivery [23]. In this study, we used a methanol extract of C. asiatica 
loaded PVP-coated iron oxide nanoparticle against human breast 
cancer cell lines MCF-7.
Initially, dose-dependent hydrogen peroxide free radical scavenging 
activity was carried out for a methanol extract of C. asiatica 80% 
inhibition, respectively. From this, it’s clear the hydrogen peroxide 
activity increases when the concentration of the sample increases. 
Inhibition of hydrogen peroxide scavenging activity is an important 
principle for cancer drugs. Hydrogen peroxide initiated the cancer 
development by means of converting the reactive hydroxyl radicals, 
which are connected with DNA damage, mutation, and genetic 
instability [24]. The results were clear that antioxidant principle of the 
secondary metabolites present in the plant sample may act as chemo-
defensive by keeping H2O2 levels under physiological level and prevent 
the cellular or metabolic damage and resembles the character of a 
chemotherapeutic drug.
The UV spectrum analysis confirmed the drug loading efficiency of the 
PVP-coated iron oxide nanoparticle with the methanol extract of the 
C. asiatica showed efficiency at 78% compared to uncoated iron oxide 
nanoparticles efficiency 75% after 24 hrs.
FTIR results confirmed drug loaded polymer PVP-coated iron oxide 
nanoparticle with the methanolic extracts of Centella asiatica shown 
carbonyl group absorption at 1633/cm and 1657/cm, respectively. 
Stretching mode exhibited a red-shift from 1660/cm and 1606/cm, 
respectively. PVP has O and N atom in its five-atom ring, and they can 
associate with the metal oxide on the nanoparticle crystals. The average 
particle size estimated for the PVP-coated iron oxide nanoparticle size 
was obtained in the range of 17-35 nm. While the particle size 202 nm 
was obtained for methanol extract of C. asiatica loaded PVP-coated 
iron oxide nanoparticle. In this drug loaded PVP-coated iron oxide 
nanoparticle increases in size when compared to iron oxide coated 
particles; this will be due to the coating of polymer along with the drug 
gradually increasing the size.
Fig. 8: Transmission electron microscopic (TEM) images of the 
synthesized nanoparticles. (a) TEM image of synthesized iron 
oxide nanoparticles (IONP), (b) TEM image of polymer-coated 
iron oxide nanoparticles, (c) TEM image of drug loaded IONP
Fig. 9: Cytotoxic study on Normal (L929) cell lines - Confocal 
microscopic images of cell distribution after treatment with 
drug loaded iron oxide nanoparticles. (a) Concentration-1 µl, 
(b) Concentration-5 µl, (c) Concentration-10 µl, (d) Control
Table 1: Percentage viabilities of different cell lines used for 
cytotoxic studies
Percentage cell viability






IONP 1 µl 98.2 67.32
5 µl 98 58.90
10 µl 90.1 51.67
DLIONP 1 µl 70 68
5 µl 69 50
10 µl 60 40
C. asiatica (drug) 1 µl 76 64
5 µl 74 55
10 µl 70.4 50.2
5-fluorouracil 1 µl 70.1 89.8
5 µl 69.8 86.3
10 µl 65 80.9
C. asiatica: Centella asiatica, IONP: Iron oxide nanoparticles, DLIONP: Drug 





Fig. 10: Cytotoxic study of breast cancer cell lines - (michigan 
cancer foundation - 7 type) - confocal microscopic images of 
cell distribution after treatment with drug loaded iron oxide 
nanoparticles. (a) Concentration-1 µl, (b) Concentration-5 µl, 
(c) Concentration-10 µl, (d) Control
dc
ba
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The cell line assay is the most important method to analyze various 
expose of cell necrosis to provide information about the cell death, 
survival rate, and metabolic activity [25]. In vitro studies of drug loaded 
PVP-coated iron oxide nanoparticles were analyzed in normal cell lines 
(L929) and breast cancer cell lines (MCF-7). At 10 µl concentrations of 
methanol extract of methanol extract of C. asiatica loaded PVP-coated 
iron oxide nanoparticle shown 60% cell necrosis in breast cancer cell 
lines (MCF-7) compare to C. asiatica methanol extract loaded iron 
oxide nanoparticle as 48.33%, respectively. The anticancer activity of 
standard compound are low as 19.1% compared to methanol extract 
of C. asiatica loaded PVP-coated iron oxide nanoparticle and methanol 
extract of C. asiatica. There are many reports stating that the efficiency 
of the polymer-coated iron oxide nanoparticle along with the drug 
molecule will act as the cell-specific delivery and kill the uptake cancer 
cells [26,27].
CONCLUSION
Our study makes another proof the efficiency of the methanol extract 
of C. asiatica loaded PVP-coated iron oxide nanoparticle act as the 
effective against breast cancer. The overall results make clear that 
C. asiatica loaded PVA-coated iron oxide nanoparticles will be the 
effective alternative drug to treat cancer, and the results make another 
conclusion that drug coated with the nanoparticle may lead to greater 
impact in the cancer clinical area as target-based drug delivery.
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